115 related articles for article (PubMed ID: 9724093)
41. The selective epidermal growth factor receptor tyrosine kinase inhibitor PD153035 suppresses expression of prometastasis phenotypes in malignant pleural mesothelioma cells in vitro.
Cole GW; Alleva AM; Reddy RM; Maxhimer JB; Zuo J; Schrump DS; Nguyen DM
J Thorac Cardiovasc Surg; 2005 May; 129(5):1010-7. PubMed ID: 15867774
[TBL] [Abstract][Full Text] [Related]
42. Effect of hepatocyte growth factor on invasion of prostate cancer cell lines.
Fujiuchi Y; Nagakawa O; Murakami K; Fuse H; Saiki I
Oncol Rep; 2003; 10(4):1001-6. PubMed ID: 12792760
[TBL] [Abstract][Full Text] [Related]
43. Chemotaxis and haptotaxis of human malignant mesothelioma cells: effects of fibronectin, laminin, type IV collagen, and an autocrine motility factor-like substance.
Klominek J; Robért KH; Sundqvist KG
Cancer Res; 1993 Sep; 53(18):4376-82. PubMed ID: 8364933
[TBL] [Abstract][Full Text] [Related]
44. Granulocyte-macrophage colony-stimulating factor induces human melanoma-cell migration.
Kohn EC; Hollister GH; DiPersio JD; Wahl S; Liotta LA; Schiffmann E
Int J Cancer; 1993 Apr; 53(6):968-72. PubMed ID: 8473054
[TBL] [Abstract][Full Text] [Related]
45. Creatine biosynthesis during embryonic development. False feedback suppression of liver amidinotransferase by N-acetimidoylsarcosine and 1-carboxymethyl-2-iminoimidazolidine (cyclocreatine).
Walker JB; Hannan JK
Biochemistry; 1976 Jun; 15(12):2519-22. PubMed ID: 938623
[TBL] [Abstract][Full Text] [Related]
46. TPA-enhanced invasion of Matrigel associated with augmentation of cell motility but not metalloproteinase activity in a highly metastatic variant (L-10) of human rectal adenocarcinoma cell line RCM-1.
Nabeshima K; Komada N; Kishi J; Koita H; Inoue T; Hayakawa T; Koono M
Int J Cancer; 1993 Dec; 55(6):974-81. PubMed ID: 8253535
[TBL] [Abstract][Full Text] [Related]
47. Thrombospondin-induced tumor cell migration: haptotaxis and chemotaxis are mediated by different molecular domains.
Taraboletti G; Roberts DD; Liotta LA
J Cell Biol; 1987 Nov; 105(5):2409-15. PubMed ID: 3680388
[TBL] [Abstract][Full Text] [Related]
48. Involvement of focal adhesion kinase in inhibition of motility of human breast cancer cells by sphingosine 1-phosphate.
Wang F; Nohara K; Olivera A; Thompson EW; Spiegel S
Exp Cell Res; 1999 Feb; 247(1):17-28. PubMed ID: 10047444
[TBL] [Abstract][Full Text] [Related]
49. Recombinant interferon alpha and gamma modulate the invasive potential of human melanoma in vitro.
Hujanen ES; Turpeenniemi-Hujanen T
Int J Cancer; 1991 Feb; 47(4):576-81. PubMed ID: 1847357
[TBL] [Abstract][Full Text] [Related]
50. Calpain-2 as a target for limiting prostate cancer invasion.
Mamoune A; Luo JH; Lauffenburger DA; Wells A
Cancer Res; 2003 Aug; 63(15):4632-40. PubMed ID: 12907643
[TBL] [Abstract][Full Text] [Related]
51. Evaluation of chronic toxicity of cyclocreatine in beagle dogs after oral gavage administration for up to 23 weeks.
Wallery JJ; Kale VP; Novak J; Gibbs S; Do MT; McKew JC; Terse PS
Toxicol Appl Pharmacol; 2021 Nov; 430():115680. PubMed ID: 34411581
[TBL] [Abstract][Full Text] [Related]
52. An autocrine motility factor secreted by the Dunning R-3327 rat prostatic adenocarcinoma cell subtype AT2.1.
Evans CP; Walsh DS; Kohn EC
Int J Cancer; 1991 Aug; 49(1):109-13. PubMed ID: 1874563
[TBL] [Abstract][Full Text] [Related]
53. High-performance liquid chromatographic assays for free and phosphorylated derivatives of the creatine analogues beta-guanidopropionic acid and 1-carboxy-methyl-2-iminoimidazolidine (cyclocreatine).
Wiseman RW; Moerland TS; Chase PB; Stuppard R; Kushmerick MJ
Anal Biochem; 1992 Aug; 204(2):383-9. PubMed ID: 1443539
[TBL] [Abstract][Full Text] [Related]
54. Creatine and cyclocreatine effects on ischemic myocardium: 31P nuclear magnetic resonance evaluation of intact heart.
Osbakken M; Ito K; Zhang D; Ponomarenko I; Ivanics T; Jahngen EG; Cohn M
Cardiology; 1992; 80(3-4):184-95. PubMed ID: 1511465
[TBL] [Abstract][Full Text] [Related]
55. Modulation of type-IV collagenase activity and invasive behavior of metastatic human melanoma (A2058) cells in vitro by monoclonal antibodies to type-IV collagenase.
Höyhtyä M; Hujanen E; Turpeenniemi-Hujanen T; Thorgeirsson U; Liotta LA; Tryggvason K
Int J Cancer; 1990 Aug; 46(2):282-6. PubMed ID: 2166712
[TBL] [Abstract][Full Text] [Related]
56. Comparison of autocrine mechanisms promoting motility in two metastatic cell lines: human melanoma and ras-transfected NIH3T3 cells.
Seiki M; Sato H; Liotta LA; Schiffmann E
Int J Cancer; 1991 Nov; 49(5):717-20. PubMed ID: 1657797
[TBL] [Abstract][Full Text] [Related]
57. Autotaxin promotes motility via G protein-coupled phosphoinositide 3-kinase gamma in human melanoma cells.
Lee HY; Bae GU; Jung ID; Lee JS; Kim YK; Noh SH; Stracke ML; Park CG; Lee HW; Han JW
FEBS Lett; 2002 Mar; 515(1-3):137-40. PubMed ID: 11943209
[TBL] [Abstract][Full Text] [Related]
58. Differential effects of creatine kinase isoenzymes and substrates on regeneration in livers of transgenic mice.
Askenasy N; Koretsky AP
Am J Physiol; 1997 Aug; 273(2 Pt 1):C741-6. PubMed ID: 9277372
[TBL] [Abstract][Full Text] [Related]
59. Macrovipecetin, a C-type lectin from Macrovipera lebetina venom, inhibits proliferation migration and invasion of SK-MEL-28 human melanoma cells and enhances their sensitivity to cisplatin.
Hammouda MB; Riahi-Chebbi I; Souid S; Othman H; Aloui Z; Srairi-Abid N; Karoui H; Gasmi A; Magnenat EM; Wells TNC; Clemetson KJ; Rodríguez-López JN; Essafi-Benkhadir K
Biochim Biophys Acta Gen Subj; 2018 Mar; 1862(3):600-614. PubMed ID: 29196192
[TBL] [Abstract][Full Text] [Related]
60. 12(S)-HETE enhancement of prostate tumor cell invasion: selective role of PKC alpha.
Liu B; Maher RJ; Hannun YA; Porter AT; Honn KV
J Natl Cancer Inst; 1994 Aug; 86(15):1145-51. PubMed ID: 7518003
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
